BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29328404)

  • 1. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
    Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells.
    Liang L; Huang J
    Oncol Rep; 2016 Sep; 36(3):1333-8. PubMed ID: 27430890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
    Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
    Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
    Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
    Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
    Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased EWSAT1 expression promotes cell proliferation, invasion and epithelial-mesenchymal transition in colorectal cancer.
    Zhang R; Li JB; Yan XF; Jin K; Li WY; Xu J; Zhao J; Bai JH; Chen YZ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6801-6808. PubMed ID: 30402843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
    Mao TL; Fan MH; Dlamini N; Liu CL
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
    Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
    Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
    Jiang X; Li D; Wang G; Liu J; Su X; Yu W; Wang Y; Zhai C; Liu Y; Zhao Z
    Oncol Rep; 2020 Apr; 43(4):1245-1255. PubMed ID: 32323831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
    Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
    Oncol Rep; 2017 Feb; 37(2):747-753. PubMed ID: 27959430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α).
    Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L
    Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G
    Cell Signal; 2019 May; 57():21-28. PubMed ID: 30716387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA XIST Regulates miR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer.
    Liu X; Cui L; Hua D
    Oncol Res; 2018 Dec; 27(1):99-106. PubMed ID: 29495975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.